网络药理学预测UA在向子宫内膜异位症进展到子宫内膜癌的预测中
Jayhind Kumar Chauhan1, Pradeep Kumar1, Sangeeta Rai2
1Zoology Section, MMV, Department of Zoology, Banaras Hindu University, Varanasi, Uttar Pradesh 221005 India.
In silico pharmacology
|December 1, 2025
概括
乌尔索酸 (UA) 显示出防止子宫内膜异位症发展为子宫内膜癌的潜力. 这项研究使用了网络药理学来识别关键的基因和途径,通过对人类子宫内膜细胞的实验进行验证.
科学领域:
- 妇科瘤学 妇科瘤学
- 药理学 药理学是指药理学的学科.
- 计算生物学是一种计算生物学.
背景情况:
- 子宫内膜异位症 (EMS) 是生殖年龄女性常见的妇科疾病.
- 虽然EMS是子宫内膜癌 (EMC) 的潜在危险因素,但过渡机制尚不清楚.
研究的目的:
- 研究乌尔索酸 (UA) 在调节从EMS到EMC的进展方面的治疗潜力.
- 通过网络药理学方法阐明这种转变背后的分子机制.
主要方法:
- 网络药理学用于预测UA目标基因 (瑞士目标预测,TargetNet,GeneCards).
- 基于相互作用程度的核心基因 (例如TNF,IL6,AKT1) 的优先级.
- 基因本体学,KEGG通路分析,mRNA表达,免疫组织化学,分子对接.
- 实验验证使用实时PCR,MTT测定,在人类子宫内膜细胞上进行AO/PI染色.
主要成果:
- 确定了132个UA目标基因,优先考虑了参与EMS到EMC进展的十个核心基因.
- 揭示了关键的信号通路和与过渡有关的基因相互作用.
- 实验验证证了UA对人类初级子宫内膜细胞的影响.
结论:
- 氨酸在缓解EMS到EMC进展方面显示出有前途的治疗潜力.
- 在这种情况下,这项研究为UA的分子机制提供了新的见解.
更多相关视频
08:16Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis
Published on: February 26, 2019
8.6K
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.7K
相关概念视频
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
